A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer
Open Access
- 1 July 1998
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (2) , 251-256
- https://doi.org/10.1038/bjc.1998.473
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)Annals of Oncology, 1995
- Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.Journal of Clinical Oncology, 1990
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in miceCancer Chemotherapy and Pharmacology, 1988
- Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivoCancer Chemotherapy and Pharmacology, 1988
- ANTITUMOR-ACTIVITY OF 7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, A NOVEL WATER-SOLUBLE DERIVATIVE OF CAMPTOTHECIN, AGAINST MURINE TUMORS1987
- Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.Proceedings of the National Academy of Sciences, 1987
- A New International Staging System for Lung CancerChest, 1986
- Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.1975